Injective (INJ) is up 11.5% to $6.68, outperforming Bitcoin and the broader market. Main catalyst: • Kraken's acquisition of Bitnomial brought attention back to INJ after Bitnomial launched the first CFTC-regulated futures contracts tied to Injective, improving institutional access and credibility. Additional drivers: • Continued rotation into AI-related and infrastructure crypto narratives. • Short covering and rising derivatives activity helped accelerate the move, with open interest climbing sharply. Key levels: • Support: $6.47 • Major support: $6.15 • Resistance: $6.76 • Breakout target: $7.00+ Outlook: The short-term trend remains bullish while INJ holds above $6.47. A breakout above $6.76 could open the door to $7.00 and higher. However, if Bitcoin weakens further, INJ could see a pullback toward the $6.15 support zone. Bottom line: INJ's rally is being driven by a meaningful institutional catalyst rather than pure speculation. The next test is whether buyers can push price through $6.76 and maintain momentum. 🚀